Drug – bio-affecting and body treating compositions – Enzyme or coenzyme containing – Hydrolases
Patent
1997-08-26
1998-11-17
Jacobson, Dian C.
Drug, bio-affecting and body treating compositions
Enzyme or coenzyme containing
Hydrolases
4242341, 435227, 514925, 514926, 514927, A61K 3846, A61K 3902, A61K 39106
Patent
active
058372407
ABSTRACT:
Methods and compositions are provided for prophylactic and antibacterial therapy for Helicobacter, particularly for Helicobacter pylori, infection of humans. The immunogenic composition of the invention is composed of a plurality of multimeric complexes, each complex being composed of recombinant, enzymatically inactive Helicobacter pylori urease. Each multimeric complex is composed of six Urease A subunits and six Urease B subunits. Alternatively, the composition is composed of a mixture of multimeric complexes, wherein each multimeric complex in the mixture is composed of six Urease A subunits and six Urease B subunits or four Urease A subunits and four Urease B subunits.
REFERENCES:
Michetti, P. et al., Gastroenterology 107(4):1002-1011 (1994).
Davin, C. et al., Gastroenterology 104(4):A1035 (1993).
Pallen, M.J. et al., Lancet 336:156-157 (1990).
Hu, Li-Tai et al., Infection and Immunity, vol. 60, No. 7, (Jul. 1992), pp. 2657-2666.
Ackerman Samuel K.
Bhagat Hitesh
Ermak Thomas
Guirakhoo Farshad
Kleanthous Harold
Jacobson Dian C.
OraVax-Merieux Co.
LandOfFree
Multimeric, recombinant urease vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Multimeric, recombinant urease vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Multimeric, recombinant urease vaccine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-881358